Walgreens Boots Alliance (NASDAQ: WBA) announced better-than-expected Q3 financial numbers. However, its stock closed almost 7% lower on Thursday. Multiple factors, including the year-over-year ...

Drugstore chain Walgreens reported third-quarter sales were up nearly 9% to reach $35.4 billion, but the company slashed its profit outlook for the year as it faces lower consumer spending and a dr ...

Walgreens Boots Alliance (NASDAQ: WBA) reported third-quarter earnings last week, and investors were down on the results. The stock fell to a new 52-week low as the company's sales and profits ...

Walgreens reported a 7% jump in sales to reach $39 billion in its fiscal third quarter, reflecting sales growth in its U.S. retail pharmacy and international segments as well as improvements in ...

Walgreens released the company's financial results press release for the second quarter of fiscal 2022 on March 31, 2022, and WBA's non-GAAP adjusted earnings per share or EPS expanded by +26% YoY ...

Walgreens Boots Alliance (WBA) reported $38.99 billion in revenue for the quarter ended May 2025, representing a year-over-year increase of 7.3%. EPS of $0.38 for the same period compares to $0.63 ...

Walgreens' Q3 FY ‘22 earnings announcement was a disaster for WBA stock, sending shares below $37, on top of an already lousy year. Read more here.

Walgreens posts Q3 2023 revenue growth, misses EPS estimates. Open in App ...

Walgreens Boots Alliance ... will release its Fiscal 2023 third quarter financials on Tuesday, June 27, 2023 ... Q3 Expectations. Analysts expect Walgreens to post revenue of $34.23 ...

On Thursday, Walgreens Boots Alliance Inc (NASDAQ: WBA) reported third-quarter fiscal year 2024 sales of $36.35 billion, up 2.6% year over year (+2.5% on constant currency), beating the consensus ...